Rotavirus VLP vaccine - Wyeth

Drug Profile

Rotavirus VLP vaccine - Wyeth

Latest Information Update: 06 Oct 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Wyeth
  • Class Rotavirus vaccines; Virus-like particle vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Rotavirus infections

Most Recent Events

  • 22 Jun 2001 No-Development-Reported for Rotavirus infections in USA (Unknown route)
  • 05 Dec 1996 Preclinical studies have been added to the Viral Infections immunogenicity section
  • 27 Sep 1996 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top